Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2008-05-27
2008-05-27
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001370, C424S001650, C424S001810, C424S001850, C424S001890, C534S014000
Reexamination Certificate
active
07378079
ABSTRACT:
The present invention provides novel compounds that bind selectively to cells undergoing perturbations and alterations of the normal organization of their plasma membrane, while binding to a lesser degree to cells having membranes of normal organization, and their uses as diagnostic probes. Said compounds and methods used therein may be useful in medical practice, for applications such as diagnosis of disease and monitoring of response to therapy.
REFERENCES:
patent: 0451 824 (1991-10-01), None
patent: WO 02/46147 (2002-06-01), None
patent: WO 02/074346 (2002-09-01), None
Golub et al., Science, Oct. 15, 1999, pp. 531-537.
Wilkinson (Journal of Chromatographic Science, 1978, vol. 16, No. 11, pp. 547-552).
Chiotellis, E. et al. “Structure-Activity Relationships of Some Technetium-99m Labeled [(Thioethyl)amino] Carboxylates”,J. Med. Chem, vol. 25 pp. 1370-1374, 1982.
Lazarides, E. et al. “Fluorescent localization of membrane sites in glycerinated chicken skeletal muscle fibers and the relationship of these sites to the protein composition of the Z disc”, Proc.Natl.Acad.Sci.USA, vol. 75(8) pp. 3683-3687, 1978.
Bevers, E.M. et al. “Lipid translocation across the plasma membrane of mammalian cells”,Biochimica et Biophysica Acta, vol. 1439 pp. 317-330, 1999.
Bombeli, T. et al. “Apoptic Vascular Endothelial Cells Become Procoagulant”,Blood, vol. 89(7) pp. 2429-2442, 1997.
Bratton, D.L. et al. “Appearance of Phosphatidylserine on Apoptotic Cells Requires Calcium-mediated Nonspecific Flip-Flop and is Enhanced by Loss of the Aminophospholipid Translocase”,The Journal of Biological Chemistry, vol. 272(42) pp. 26159-26165, 1997.
Bursch, W. et al. “Cell death by apoptosis and its protective role against disease”,TiPS, vol. 13 pp. 245-251, 1992.
Kockx, M.M. et al. “Apoptosis in atherosclerosis: beneficial or detrimental?”,Cardiovascular Research, vol. 45 pp. 736-746, 2000.
Mallat, Z. et al. “Colocalization of CPP-32 With Apoptotic Cells in Human Atherosclerotic Plaques”,Circulation, vol. 96 pp. 424-428, 1997.
Martin, S.J. et al. “Early Redistribution of Plasma Membrane Phosphatidylserine is a General Feature of Apoptosis Regardless of the Initiating Stimulus: Inhibition by Overexpression of Bcl-2 and Abl”, J. Exp. Med., vol. 182 pp. 1545-1556, 1995.
Sims, P.J. et al. “Unraveling the Mysteries of Phospholipid Scrambling”,Thromb Haemost, vol. 86 pp. 266-275, 2001.
Stary, H.C. et al. “A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis”,Circulation, vol. 92 pp. 1355-1374, 1995.
Van den Eijnde, S.M. et al. “Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis”,Cell Death and Differentiation, vol. 4 pp. 311-316, 1997.
Ebner Sharon
Shirvan Anat
Ziv Ilan
Hopkins Susanne M.
Jones Dameron L.
Nath Gary M.
NST Neurosurvival Technologies Ltd.
The Nath Law Group
LandOfFree
Agents for imaging and diagnostic methods using them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for imaging and diagnostic methods using them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for imaging and diagnostic methods using them will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2755992